214
Participants
Start Date
March 1, 2021
Primary Completion Date
October 30, 2025
Study Completion Date
October 30, 2030
omit of IMI group
clincial high risk breast (≥2 risk factors)patients with 18-gene low risk an indication for regional nodal irradiation will received 2 Gy for 25 fractions to chest wall or whole breast and supraclavicular lymph nodes irradiation and sequential tumor bed boost of 2 Gy for 5 fractions following breast conserving surgery.
IMI group
clincial high risk breast (≥2 risk factors)patients with 18-gene low risk an indication for regional nodal irradiation will received 2 Gy for 25 fractions to chest wall or whole breast and supraclavicular lymph nodes irradiation and sequential tumor bed boost of 2 Gy for 5 fractions following breast conserving surgery.
RECRUITING
Ruijin Hospital, Shanghai jiaotong univestigy school of medicine, Shanghai
Ruijin Hospital
OTHER